145 related articles for article (PubMed ID: 9059944)
1. Immunogenicity of two versus three injections of inactivated hepatitis A vaccine in adults.
Chen XQ; Bülbül M; de Gast GC; van Loon AM; Nalin DR; van Hattum J
J Hepatol; 1997 Feb; 26(2):260-4. PubMed ID: 9059944
[TBL] [Abstract][Full Text] [Related]
2. Immunogenicity and reactogenicity of a combined hepatitis A and B vaccine in young adults.
Bruguera M; Bayas JM; Vilella A; Tural C; González A; Vidal J; Dal-Ré R; Salleras L
Vaccine; 1996 Oct; 14(15):1407-11. PubMed ID: 8994314
[TBL] [Abstract][Full Text] [Related]
3. Inactivated hepatitis A vaccine: reactogenicity, immunogenicity, and long-term antibody persistence.
Van Damme P; Thoelen S; Cramm M; De Groote K; Safary A; Meheus A
J Med Virol; 1994 Dec; 44(4):446-51. PubMed ID: 7897379
[TBL] [Abstract][Full Text] [Related]
4. Single dose-inactivated hepatitis A vaccination schedule for susceptible youngsters.
Lee SD; Chan CY; Yu MI; Wang YJ; Lo KJ; Safary A
Am J Gastroenterol; 1996 Jul; 91(7):1360-2. PubMed ID: 8677995
[TBL] [Abstract][Full Text] [Related]
5. Does immunoglobulin interfere with the immunogenicity to Pasteur Mérieux inactivated hepatitis A vaccine?
Zanetti A; Pregliasco F; Andreassi A; Pozzi A; Viganò P; Cargnel A; Briantais P; Vidor E
J Hepatol; 1997 Jan; 26(1):25-30. PubMed ID: 9148018
[TBL] [Abstract][Full Text] [Related]
6. Comparison of immunogenicity of two hepatitis A vaccines--VAQTA and HAVRIX--in young adults.
Ashur Y; Adler R; Rowe M; Shouval D
Vaccine; 1999 May; 17(18):2290-6. PubMed ID: 10403597
[TBL] [Abstract][Full Text] [Related]
7. Follow-up immunogenicity of an inactivated hepatitis A virus vaccine in healthy children: results after 5 years.
Fan PC; Chang MH; Lee PI; Safary A; Lee CY
Vaccine; 1998; 16(2-3):232-5. PubMed ID: 9607035
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity, safety and tolerability of varying doses and regimens of inactivated hepatitis A virus vaccine in Navajo children.
Newcomer W; Rivin B; Reid R; Moulton LH; Wolff M; Croll J; Johnson C; Brown L; Nalin D; Santosham M
Pediatr Infect Dis J; 1994 Jul; 13(7):640-2. PubMed ID: 7970954
[TBL] [Abstract][Full Text] [Related]
9. Inactivated hepatitis A vaccine: a safety and immunogenicity study in health professionals.
Sandman L; Davidson M; Krugman S
J Infect Dis; 1995 Mar; 171 Suppl 1():S50-2. PubMed ID: 7876649
[TBL] [Abstract][Full Text] [Related]
10. Effect of virus strain and antigen dose on immunogenicity and reactogenicity of an inactivated hepatitis A vaccine.
Goubau P; Van Gerven V; Safary A; Delem A; Knops J; D'Hondt E; André FE; Desmyter J
Vaccine; 1992; 10 Suppl 1():S114-8. PubMed ID: 1335638
[TBL] [Abstract][Full Text] [Related]
11. Long-term persistence of anti-HAV antibodies following active immunization with hepatitis A vaccine.
Maiwald H; Jilg W; Bock HL; Löscher T; Sonnenburg F
Vaccine; 1997 Mar; 15(4):346-8. PubMed ID: 9141202
[TBL] [Abstract][Full Text] [Related]
12. Safety and immunogenicity of an inactivated hepatitis A vaccine in preschool children.
Balcarek KB; Bagley MR; Pass RF; Schiff ER; Krause DS
J Infect Dis; 1995 Mar; 171 Suppl 1():S70-2. PubMed ID: 7876652
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis A vaccine: persistence of antibodies 5 years after the first vaccination.
Totos G; Gizaris V; Papaevangelou G
Vaccine; 1997 Aug; 15(11):1252-3. PubMed ID: 9286052
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity and safety of an inactivated hepatitis A vaccine amongst Singaporeans.
Guan R; Ng HS; Fock KM; Ho KY; Yap I; Kang JY; Chow WC; Chew CN; Ng C; Teo CJ
Southeast Asian J Trop Med Public Health; 1995 Jun; 26(2):268-71. PubMed ID: 8629058
[TBL] [Abstract][Full Text] [Related]
15. Comparison of two immunization schedules with an inactivated hepatitis A vaccine (AvaximTM).
Vidor E; Ratheau C; Briantais P; Vuillier D
J Travel Med; 1998 Dec; 5(4):167-72. PubMed ID: 9876189
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis A antibody titres after infection and immunization: implications for passive and active immunization.
Zaaijer HL; Leentvaar-Kuijpers A; Rotman H; Lelie PN
J Med Virol; 1993 May; 40(1):22-7. PubMed ID: 8515245
[TBL] [Abstract][Full Text] [Related]
17. Mathematical models for assessment of long-term persistence of antibodies after vaccination with two inactivated hepatitis A vaccines.
Van Herck K; Beutels P; Van Damme P; Beutels M; Van den Dries J; Briantais P; Vidor E
J Med Virol; 2000 Jan; 60(1):1-7. PubMed ID: 10568755
[TBL] [Abstract][Full Text] [Related]
18. Safety and immunogenicity of inactivated hepatitis A vaccine in patients with chronic liver disease.
Lee SD; Chan CY; Yu MI; Wang YJ; Chang FY; Lo KJ; Safary A
J Med Virol; 1997 Jun; 52(2):215-8. PubMed ID: 9179771
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity of booster vaccination with a virosomal hepatitis A vaccine after primary immunization with an aluminum-adsorbed hepatitis A vaccine.
Beck BR; Hatz CF; Loutan L; Steffen R
J Travel Med; 2004; 11(4):201-6. PubMed ID: 15541221
[TBL] [Abstract][Full Text] [Related]
20. Safety and immunogenicity of an inactivated hepatitis A vaccine in children 2 to 5 years old.
Arístegui J; Morales JL; Dal-Ré R; González A; Gallego MS; Garrote E
Infection; 1995; 23(5):334-8. PubMed ID: 8557400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
